2 weeks ago from Twitter Web App
U.S. health care in a nutshell1. FDA approves Alzehimer's drug that may not even work2. Drug costs $56,000, which will drive up insurance premiums for everyone else3. Drug maker Biogen's stock surges 38%, making it $17 billion richer in one day
Despite scant evidence that it works, the drug, Aduhelm, is predicted to generate billions of dollars in revenue, much of it from Medicare.
6 people like this
Isaac Kuo, Stefani Banerian, Kenny Chaffin, John Hummel, Andrew Pam and lambjams like this.
Hank G ☑️ likes this.